Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is a standard treatment for relapsed or refractory B-cell non-Hodgkin lymphomas. Long-term results and curative potential remain uncertain. We ...
Note. You can use Microsoft Visual Studio to search the entire set of source code here to see whether the usage of a particular Windows API is being demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results